Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pulmonary Hypertension
•
Diffuse Parenchymal Lung Disease
•
General Pulmonary
What strategies are effective for managing cough in patients receiving inhaled treprostinil?
Related Questions
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
Are there benefits to adding IL5/IL5 receptor blockade in patients with vasculitic manifestations of EGPA?
Do you utilize cytokine panels to guide treatment of patients with EGPA?
How do you mitigate risk when performing bronchoscopy in hypoxic patients requiring high levels of supplemental oxygen?
Is it clinically necessary to provide supplemental oxygen to patients with mild, asymptomatic hypoxemia only during activity while they are recovering from an acute respiratory illness?
When do you consider systemic therapy for patients with progressive fibrosing mediastinitis?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
When interpreting pulmonary function tests (PFTs), do you include diagnostic language such as 'findings are suggestive of COPD,' or do you limit your report to a descriptive interpretation of the data?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
How do you approach pre-operative risk assessment and optimization in a patient with interstitial lung disease?
